UK markets closed

NexImmune, Inc. (NEXI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.6000+0.1400 (+4.05%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.94M
Enterprise value 358.10k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.41
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.53

Trading information

Stock price history

Beta (5Y monthly) 2.06
52-week change 3-48.57%
S&P500 52-week change 326.27%
52-week high 328.6950
52-week low 31.2500
50-day moving average 34.6000
200-day moving average 35.3122

Share statistics

Avg vol (3-month) 365.37k
Avg vol (10-day) 323.26k
Shares outstanding 51.37M
Implied shares outstanding 61.37M
Float 81.15M
% held by insiders 121.94%
% held by institutions 19.71%
Shares short (30 Apr 2024) 46.24k
Short ratio (30 Apr 2024) 40.18
Short % of float (30 Apr 2024) 40.51%
Short % of shares outstanding (30 Apr 2024) 40.46%
Shares short (prior month 28 Mar 2024) 417.82k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 319 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-70.62%
Return on equity (ttm)-180.64%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -28.16M
Net income avi to common (ttm)-32.34M
Diluted EPS (ttm)-30.8200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.2M
Total cash per share (mrq)2.34
Total debt (mrq)68.81k
Total debt/equity (mrq)1.96%
Current ratio (mrq)1.06
Book value per share (mrq)3.29

Cash flow statement

Operating cash flow (ttm)-31.43M
Levered free cash flow (ttm)-17.9M